GYRE
#2645
Gyre Therapeutics, Inc. - Common Stock
6.8 6 USD
+0.07%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+6.52%
Changement Mensuel
+9.24%
Evolution sur 6 mois
-16.65%
Changement Annuel
-16.95%
Clôture Précédente
6.4 4
Open
6.8 6
Low
6.8 6
High
6.8 6
Volume
15
Financials
- Market Capitalization 764.96 M
- Employee 618
- Founded 1997
- CEO N/A
- Website www.gyretx.com
- Headquarter Delaware, United States
- FIGI BBG000F88SY8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-38.76
ratio cours/chiffre d'affaires
5.5
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2630 |  NGNE Neurogene Inc. - Common Stock | 38.60 USD | +2.63% | +8.64% | +7.19% | +31.20% | 772.44 M USD | ||
| 2635 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.50 USD | +4.97% | +3.60% | +13.37% | -22.70% | 768.56 M USD | ||
| 2664 |  ASMB Assembly Biosciences, Inc. - Common Stock | 36.60 USD | +1.30% | +8.28% | +36.67% | +24.38% | 745.20 M USD | ||
| 2668 |  VSTM Verastem, Inc. - Common Stock | 8.20 USD | +2.76% | +15.49% | +38.75% | -22.93% | 742.62 M USD |